Neusoft, a leading IT solution and service provider in China, and Israeli-Chinese private equity firm Infinity Group have agreed to form a $250-million fund to invest in Israeli medical technologies over the next three years.
“The establishment of this fund is another step in deepening the economic ties between Israel and China,” said Amir Gal-Or, Infinity Group founder and chairman of the summit.
Neusoft and Infinity made the announcement at the start of the China-Israel Investment Summit, held last week in Tel Aviv as part of the DLD Tel Aviv Innovation Conference.
As part of the deal, Israeli medtech companies will get access to Neusoft’s industry solutions, product engineering solutions and related software products and platforms. Neusoft’s connections will give the Israeli companies access to the China Food and Drug Administration (CFDA).
In 2011, Neusoft invested $1.77 million in Aerotel Medical Systems, a leading global manufacturer of modular, mobile and home based telemedicine and telecare solutions based in Holon.